| Class 2 Device Recall Guidant CONTAK RENEWAL 3 | |
Date Initiated by Firm | May 15, 2006 |
Date Posted | July 27, 2006 |
Recall Status1 |
Terminated 3 on March 02, 2008 |
Recall Number | Z-1288-06 |
Recall Event ID |
35525 |
PMA Number | P010012 |
Product Classification |
Cardiac resynchronization therapy defibrillators - Product Code NIK
|
Product | Guidant CONTAK RENEWAL 3 (models H170, H175) CONTAK RENEWAL 3 HE (models H177, H179) Cardiac Resynchronization Therapy Defibrillator (CRT-D). Guidant Corporation, 4100 Hamline Avenue North, St. Paul, MN 55112-5798 USA. Cardiac resynchronization therapy defibrillators (CRT-D) provide ventricular tachyarrhythmia and cardiac resynchronization therapies. Ventricular tachyarrhythmia therapy is for the treatment of ventricular tachycardia (VT) and ventricular fibrillation (VF), rhythms that are associated with sudden cardiac death (SCD). Cardiac resynchronization therapy is for the treatment of heart failure (HF) and uses biventricular electrical stimulation to synchronize ventricular contractions. Cardioversion/defibrillation therapies include a range of low-and high-energy shocks using either a biphasic or monophasic waveform. |
Code Information |
model H170, serial numbers: 509659, 509677, 509678, 509679, 509685, 509694, 509695, 509696, 509762, 509884, 509974, 510012 model H175, serial numbers: 512665, 512666, 512667, 512668, 512708, 512709, 512710, 512711, 512713, 512719, 512721, 512722, 512723, 512759, 512791, 512793, 513062, 513064, 513073, 513085, 513086, 513227 model H177, serial numbers: 506951, 506953, 506954, 506955, 506956, 506957, 506959, 506960, 506967, 506969, 506970, 506973, 506974, 507013, 507014, 507472 model H179, serial numbers: 508312, 508316, 508322, 508325, 508326, 508336, 508342, 508349, 508404 |
Recalling Firm/ Manufacturer |
Boston Scientific CRM Corp 4100 Hamline Ave N Saint Paul MN 55112-5700
|
For Additional Information Contact | Guidant 866-484-3268 |
Manufacturer Reason for Recall | Guidant has identified a pattern of premature battery depletion in devices manufactured with a single lot of capacitors from a single supplier. If function of this low voltage capacitor is compromised, the battery may deplete prematurely. |
FDA Determined Cause 2 | Other |
Action | An Urgent Medical Device Safety Information & Corrective Action letter, dated May 12, 2006, was sent to physicians. The letter gave a description of the issue, clinical implications, rate of occurrence, devices affected and recommendation. Physicians are asked to follow-up with affected patients as soon as possible because ERI to EOL time may be shortened. Physicians are asked to contact Guidant for instructions on performing a baseline 'save to disk' and provide this information to Guidant. Guidant will be able to analyze the device memory data and estimate remaining longevity and provide individualized follow-up and replacement guidelines. Subsequent follow-up visits should continue to monitor for evidence of premature battery depletion. |
Quantity in Commerce | 59 |
Distribution | Nationwide including Puerto Rico. Worldwide, including Argentina, Belgium, Canada, Denmark, France, Germany, Greece, Ireland, Italy, Netherlands, New Zealand, Portugal, Spain, Syrian Arab Republic, United Arab Emirates |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
PMA Database | PMAs with Product Code = NIK
|
|
|
|